Premier Alternatives

Osteal Therapeutics

Dallas, TX · Founded 2013 · Privately Held (backing)

Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. Osteal Therapeutics is based in Dallas, TX and was founded in 2013. It was valued at $576 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $133 million across 4 recorded rounds; the latest was a $15.6 million early-stage round in Oct 2025.

PMV mark · valuation
$575.6M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$133.1M
Last round
Early Stage VC
Oct 2025

Osteal Therapeutics key facts

as of Oct 2026
  • Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections.
  • Osteal Therapeutics is valued at approximately $575.6M as of Oct 2026, set at its later-stage round, Nov 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $133.1M across 4 recorded rounds; the latest was Early Stage VC ($15.6M) in Oct 2025.
  • Notable investors include Johnson & Johnson JJDC, Asteroid Partners, GOS Capital, Gideon Strategic Partners, HM Capital — 9 tracked in total.
  • Osteal Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently Jun 2024 ($50.0M sold to 16 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$575.6M

Valued at $575.6M at its later-stage round, Nov 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Osteal Therapeutics with a free account
  • ·Watch Osteal Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Osteal Therapeutics funding rounds

4 rounds
Oct 2025Early Stage VC$15.6MSEC filing▮
May 2024Early Stage VC$50.0MSEC filing▮
Aug 2023Early Stage VC$22.3MSEC filing▮
Dec 2021Early Stage VC$30.2MSEC filing▮
Full funding history →

Osteal Therapeutics valuation

Osteal Therapeutics was valued at $576 million at its later-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Osteal Therapeutics raised?

Osteal Therapeutics has raised $133 million across 4 recorded rounds since 2021. The largest was a $50 million early-stage round in May 2024; the most recent was a $15.6 million early-stage round in Oct 2025.

Osteal Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently in Jun 2024 ($50 million sold to 16 investors).

Osteal Therapeutics investors

9 investors are on record for Osteal Therapeutics, including Johnson & Johnson JJDC, Asteroid Partners, GOS Capital and Gideon Strategic Partners. The early-stage round in Oct 2025 drew 10 investors.

About Osteal Therapeutics

Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. The company's therapeutics offers a drug and device combination product to treat orthopedic infections, infected joint prosthesis, and their consequences, and provide a fast and reliable treatment option, enabling orthopedic surgeons to offer an effective treatment for musculoskeletal diseases.

Sector
Healthcare
HQ
Dallas, TX, United States
Founded
2013
Employees
49
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.